Reviewer - Tari A. King | Harvard Medical School | 3848
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tari A. King

Tari A. King
Associate Professor of Surgery
Deputy Chief and Director of Research
Memorial Sloan-Kettering Cancer Center
New York, USA


Tari A. King, M.D. is the Deputy Chief and Director of Research for the Breast Service in the Department of Surgery at Memorial Sloan-Kettering Cancer Center, the incumbent of the Jeanne A. Petrek Junior Faculty Chair and an Associate Professor of Surgery at the Weill Medical College of Cornell, New York. She received her MD degree in 1996 from the University of Colorado Health Sciences Center and completed her surgical residency at the Ochsner Clinic, in New Orleans in 2001. Following a 2 year breast surgery fellowship at Memorial Sloan-Kettering Cancer Center she joined the MSKCC faculty in 2003. Her clinical expertise is in the diagnosis and surgical treatment of breast cancer. Dr. King is also the PI of the Breast Surgery Research Laboratory at Memorial Sloan-Kettering Cancer Center and has received several awards including the SSO Clinical Investigator Award in Breast Cancer Research (2008), a Career Catalyst Award (2009) and an Investigator Initiated Research Award (2012) from the Susan G. Komen for the Cure Foundation to support her work on molecular predictors of the development of invasive carcinoma in patients with lobular carcinoma in situ. Dr. King is also the PI of a multi-institutional prospective trial investigating the role of surgery in Stage IV breast cancer sponsored by the Translational Breast Cancer Research Consortium.

Research Interest

Global Speakers in the subject

Global Experts in the subject